MedPath

Aveed

These highlights do not include all the information needed to use AVEED safely and effectively.  See full prescribing information for AVEED. AVEED (testosterone undecanoate) injection,    CIIIInitial U.S. Approval: 1953

Approved
Approval ID

f80f025b-17d8-40af-8739-20ce07902045

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Aug 24, 2021

Manufacturers
FDA

Endo Pharmaceuticals Inc.

DUNS: 178074951

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

testosterone undecanoate

PRODUCT DETAILS

NDC Product Code67979-511
Application NumberNDA022219
Marketing CategoryC73594
Route of AdministrationINTRAMUSCULAR
Effective DateJanuary 10, 2023
Generic Nametestosterone undecanoate

INGREDIENTS (3)

TESTOSTERONE UNDECANOATEActive
Quantity: 250 mg in 1 mL
Code: H16A5VCT9C
Classification: ACTIB
CASTOR OILInactive
Code: D5340Y2I9G
Classification: IACT
BENZYL BENZOATEInactive
Code: N863NB338G
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Aveed - FDA Drug Approval Details